To identify factors that have contributed to reduced rates of death and complications after esophageal resection in a 17year period at a tertiary referral center.
Summary Background Data
There has been an evolving refinement in surgical technique and perioperative management of patients undergoing esophageal resection at Queen Mary Hospital during the past two decades. As of the end of 1998, there had been no hospital deaths among the last 105 consecutive resections performed for esophageal squamous cancer.
Methods
The results of esophageal resection for squamous cell carcinoma were analyzed using a prospective esophageal database. A longitudinal study was performed to compare and analyze rates of death and complications for three consecutive time periods.
Results
The study group comprised 710 patients who underwent one-stage esophageal resection between 1982 and 1998. A transthoracic esophagectomy was the preferred approach in 590 patients (83%). The overall hospital death rate was 11%. The leading causes of hospital death were pulmonary complications (45.5%) and progression of malignant disease (21.5%); anastomotic leakage accounted for 9% of deaths. During the study period, the hospital death rate decreased from 16% to 3.2%, and the incidence of postoperative respiratory failure decreased from 15.5% to 6.5%. Perioperative factors that correlated with the decreased death rate over time were the increased postoperative use of epidural analgesia and bronchoscopy (for clearance of pulmonary secretions), a decrease in history of smoking, and a decrease in surgical blood loss of more than 1,000 mL.
Conclusions
In this series of predominantly transthoracic esophagectomies, there has been a decline in the hospital death rate to less than 5%. These results are largely attributable to factors aimed at reducing postoperative pulmonary complications.
Cancer of the esophagus is the sixth leading cause of cancer death in Hong Kong. 1 Most of these tumors are of squamous cell origin and are located in the middle and lower thirds of the esophagus. Advanced stage of disease is seen at presentation in more than 75% of our patients. 2 Concurrent medical illnesses are common in these patients, with as many as one third having clinical evidence of chronic obstructive pulmonary disease. Despite advances in the various therapeutic modalities, surgery has remained the mainstay of treatment for patients with potentially resectable esophageal cancer. Five-year survival rates as high as 30% to 40% have been reported after curative resection in some centers. 3, 4 Esophagectomy has been associated with high rates of death and complications in the past. 5, 6 In recent years, however, experienced centers have reported reduced hospital death rates of less than 10% after transthoracic esophagectomy. 7, 8 This reduction has been attributed mainly to improvements in anesthesia, surgical techniques, and postoperative intensive care management. There is increasing evidence in the literature that the hospital death rate for complex surgical procedures such as esophagectomy is re-lated to surgical volume and experience. 9 -12 During the past two decades at Queen Mary Hospital, there has been a progressive refinement in surgical techniques and perioperative management of patients undergoing esophageal resection by a dedicated esophageal team. The purpose of the present study was to define factors that have contributed to a declining hospital death rate during a 17-year period.
METHODS
Patients with squamous cancer of the thoracic esophagus who underwent a one-stage esophageal resection between 1982 and 1998 at Queen Mary Hospital are the subjects of this study. Patient data were analyzed from a prospective esophageal database. Hospital records were reviewed when additional information was required.
Surgical treatment has been the preferred treatment option for patients with esophageal cancer at our institution. Patients were selected for nonsurgical treatment if they had nonlocoregional metastases (including organ metastases), or when medical-surgical risks were prohibitive. Otherwise, patients would undergo surgical resection as the primary treatment. In recent years, more patients underwent neoadjuvant or adjuvant treatment programs.
The details of surgical techniques have been reported previously. 13 In brief, most tumors were excised using the Lewis-Tanner approach, where a separate upper abdominal incision and right-sided posterolateral thoracotomy were used for resection. This procedure was performed mainly for tumors of the middle and lower third of the esophagus. A three-phase esophagectomy was indicated for upper-third tumors. If cancer resection was doubtful, an exploratory thoracotomy with or without tumor extirpation was often carried out first, followed by reconstruction using an upper abdominal and a left cervical incision. The conduit for esophageal replacement was brought up to the neck by the posterior mediastinal or the retrosternal route. The stomach was the preferred conduit. When a tumor encroached on the gastroesophageal junction, a proximal gastric resection was carried out as part of an esophagogastrectomy. Most of these procedures were also performed by an abdominalright thoracotomy approach. In patients whose cardiopulmonary status was judged to be suboptimal, the nonthoracotomy approaches of transhiatal or split-sternum resections were selected. The extent of lymphadenectomy varied between the thoracotomy and nonthoracotomy approaches: a two-field lymph node dissection (upper abdomen and mediastinum) was carried out for the former, whereas only mediastinal lymph node sampling was possible with the latter. In patients with obvious palliative resections, only a limited lymphadenectomy was performed.
Patients were routinely extubated in the recovery room unless they were judged to have poor cardiopulmonary reserve or if surgery had been complicated by intraoperative events and prolonged. Overall, 80% of patients were extubated immediately after surgery.
Three surgical outcomes were examined: postoperative complications, 30-day hospital death, and overall hospital death. Complications were categorized as medical or surgical. Medical complications included cardiac (myocardial infarction, heart failure, arrhythmia), major pulmonary (bronchopneumonia, aspiration pneumonia, respiratory failure requiring ventilatory support), renal failure, hepatic failure, and stroke. Surgical complications were recorded as anastomotic leakage, nonanastomotic leakage or perforation of the conduit, gangrene of the conduit, chylothorax, hemorrhage (thoracic or abdominal), intraabdominal sepsis, and gastric outlet obstruction. Thirty-day death was defined as death within 30 days of esophageal resection. Any death in the hospital after surgery was recorded as a hospital death. After recovery from surgery at Queen Mary Hospital, it was not uncommon for patients to convalesce at an offsite medical facility for socioeconomic reasons. Any death occurring during convalescence was recorded as a hospital death, including death resulting from progression or recurrence of malignant disease.
Outcome was analyzed with regard to three consecutive time periods: 1982 to 1986, 1987 to 1992, and 1993 to 1998. Changes in preoperative and surgical risk factors were evaluated during this time. Changes in postoperative management, which were instituted as part of an effort to improve outcome, were similarly assessed. An analysis was performed to determine which of these changes in perioperative variables were likely to have contributed to improvements in outcome.
Only variables that were consistently recorded throughout the study period were included in the analysis. The preoperative factors included patient age, history of smoking, preexisting pulmonary or cardiac disease, abnormal electrocardiographic findings (ischemic changes or arrhythmia), serum albumin, arterial oxygen tension (PaO 2 ), arterial carbon dioxide tension (PaCO 2 ), forced expiratory volume in 1 second (FEV 1 ), and tumor stage. Surgical factors were evaluated for the type of resection (transthoracic vs. transhiatal), the completeness of resection (curative vs. palliative), and the amount of blood loss. Whether the resection was defined as curative or palliative was decided at the time of surgery. Resection was palliative when there was infiltration of tumor beyond the esophagus into mediastinal structures, or when residual tumor or infiltrated lymph nodes were confirmed or judged likely after resection. The postoperative factors analyzed included the use of epidural analgesia and bronchoscopy. A pain management team was formed and the use of epidural analgesia was initiated in 1989. During the study period, bronchoscopy was increasingly used as part of the routine care of these patients for the clearance of pulmonary secretions.
Statistical analyses included the chi-square test, the Fisher exact test, and the Student t test where appropriate. A logistic regression analysis was used to determine predictors of death. Statistical significance was accepted at the 5% level. All statistical analyses were performed using the SPSS statistical package (SPSS Inc., Chicago, IL).
RESULTS
Seven hundred ten patients underwent esophageal resection for squamous cancer between 1982 and 1998. For the time periods 1982 to 1986, 1987 to 1992, and 1993 to 1998, the resection rates were 61%, 63%, and 61%, respectively (P ϭ .7), and the corresponding number of resections were 261, 227, and 222. The mean age of patients was 62 years and the male:female ratio was 6:1. One hundred sixty-one patients (23%) were 70 years or older. Five hundred seventy-one patients (80%) had a history of moderate or heavy smoking.
There were 434 middle-third tumors (61%), 221 lowerthird tumors (31%), 44 upper-third tumors (6%), and 11 double tumors (2%). The stage of disease at presentation was as follows; stage I, 9 patients; stage IIa, 146 patients; stage IIb, 18 patients; stage III, 501 patients; and stage IV, 36 patients. The types of surgical procedures performed are outlined in Table 1 . The approach was transthoracic in 590 patients (83.1%) and transhiatal in 119 (16.8%). One additional patient with a lower-third tumor had an esophagogastrectomy performed through an abdominal approach alone with construction of the anastomosis transhiatally in the lower mediastinum. The resection was considered palliative by the surgeon in 404 patients (57%). Mean surgical blood loss was 832 mL, and 184 patients (26%) had a blood loss of more than 1,000 mL.
Two hundred eighty patients (39%) had one or more of the complications listed in Table 2 . Atrial arrhythmia was the most common medical complication (23%). Major pulmonary complications occurred in 137 patients (19%). Eighty-one patients had a surgical complication (11%), of whom 25 had an anastomotic leak (3.5%). Seventeen of 21 patients with gastric outlet obstruction did not have a pyloric drainage procedure performed. Thirty-three patients (4.6%) required reexploration because of one of these surgical complications.
Twenty-four patients (3.4%) died within 30 days after surgery. There were 79 postoperative deaths overall, for a hospital death rate of 11%. There was no intraoperative death in this series. Postoperative pulmonary complications were the cause of death in 36 patients (45.5%), whereas recurrence or progression of malignant disease accounted for a further 17 hospital deaths (21.5%). Other causes of hospital death were less common ( Table 3 ). There were only seven deaths resulting from anastomotic leakage during the study period.
The 30-day death rate decreased from 4.6% in 1982 to 1986 to 0.5% in 1993 to 1998 (P ϭ .01), and the hospital death rate decreased from 16% to 3.2% (P ϭ .0001) ( Fig.  1 ). There was a corresponding decrease in the incidence of postoperative respiratory failure from 15.5% in 1982 to 1986 to 6.5% in 1993 to 1998 (P ϭ .006), and the incidence of bronchopneumonia decreased from 22% to 15% during the same period (P ϭ .008) (Fig. 2) . The incidence of other postoperative complications did not change significantly with time. There was no postoperative death in the last 105 consecutive cases of this series. The last hospital death was in 1995 in a patient who had an intrathoracic anastomotic leak. This was the only surgical or technical cause of death since 1988. Medical complications were the predominant cause of hospital death before 1995 ( Fig. 3 ). Death resulting from recurrence or progression of disease was not uncommon in the 1980s and was partly attributable to the longer hospital stays (including convalescence) at that time. The mean hospital stay for the period 1982 to 1987 was 37 days (range 7-385) compared with 24 days (range 8 -155) in 1993 to 1998 (P ϭ .0001).
Changes in perioperative variables were seen during the course of the study (Table 4 ). For the period 1993 to 1998, there was a significant reduction in the number of patients with a history of smoking (P ϭ .03), with a history of pulmonary disease (P ϭ .03), and with advanced stage of disease (stages III or IV) (P ϭ .02). There were also significant improvements in the mean preoperative levels of serum albumin (P ϭ .01), in PaO 2 (P ϭ .0001), and in the mean predicted FEV 1 (P ϭ .0001). During the three time periods, there was a progressive decrease in surgical blood loss (P ϭ .0001) and an increase in the postoperative use of epidural analgesia (P ϭ .0001) and bronchoscopic clearance of secretions (P ϭ .0001). In contrast, there was no change with time in the resection rate, patient age, number of patients with cardiac disease or an abnormal electrocardiogram, or the number of patients who underwent a transthoracic approach or palliative resection.
To determine which of those factors that had changed with time were predictive of hospital death, these variables were subjected to a logistic regression analysis ( Table 5 ). Factors that correlated with a decreased hospital death rate during the study period were the increased use of epidural analgesia (P ϭ .0001) and bronchoscopy (P ϭ .0001) after surgery, and a decrease in history of smoking (P ϭ .005). A decrease in the number of patients with surgical blood loss of more than 1,000 mL also correlated with a decreased hospital death rate (P ϭ .03).
DISCUSSION
When Earlam and Cunha-Melo 5 reviewed the world literature for esophageal resections before 1980, they reported a 29% hospital death rate for squamous carcinomas. While acknowledging that there was no available alternative to surgery, they concluded that "esophageal resection for squamous cell carcinoma has the highest operative mortality of any routinely performed surgical procedure." In a review of subsequently published reports from the 1980s, Muller et al 6 reported that the hospital death rate had been halved during that decade to an average of 13%. They attributed this reduction to improvements in anesthesia, surgical techniques, and intensive care medicine. Jamieson and Mathew 14 more recently reviewed the published Western experience between 1990 and 1995 and found the overall in-hospital death rate among 11,398 patients to be 11%. Reviews of published reports are likely to have underestimated the true death rate because the distinction was not always made in the past between 30-day and in-hospital death. Also, the criteria for selection of patients for resection and thence resectability rates vary widely between different series. 2, 15 Although death rates of less than 5% are commonly reported for other major surgical procedures, 16, 17 it is apparent that despite advances in perioperative care esophagectomy is still associated with one of the highest death rates. There is increasing evidence in the literature that surgical volume and experience has a significant impact on the death rate after major cancer surgery. In a retrospective study of the Surveillance, Epidemiology, and End Results (SEER) database, Begg et al 9 noted a striking reduction in the 30-day death rate after esophagectomy from 17.3% in lowvolume hospitals to 3.4% in the highest-volume hospitals. Patti et al 18 reviewed data on 1,561 esophagectomies performed in California for malignancy between 1990 and 1994. The death rate in hospitals performing more than 30 esophagectomies during the 5-year period was 4.8%, compared with 16% for hospitals performing fewer than 30. High-volume hospitals in this study, however, treated only 17% of patients. In the present series, the hospital death rate decreased from 16% to 3.2% during the study period. This result reflects an accruing experience by a dedicated esoph-ageal team in a high-volume setting and was obtained in an unselected group of patients who predominantly underwent a transthoracic approach. Similar results have been reported from other experienced centers. 7 Although it is difficult to quantitate the effects of cumulative experience and improvements in perioperative care on reducing the hospital death rate, in this study we attempted to identify some of the contributing factors.
The most commonly reported causes of death and complications after transthoracic esophagectomy have been pulmonary complications and anastomotic leakage. Major pulmonary complications occurred in 19% of patients in this series and accounted for 45.5% of the deaths. There was a significant reduction in pulmonary complications during the study period, however, which is likely to have accounted in large part for the reduction in the hospital death rate. The anastomotic leak rate was only 3.5%, accounting for 9% of the hospital deaths. The high percentage of patients in this series who died of tumor progression or recurrence reflects the poor socioeconomic status of many patients in the 1980s, who often stayed in the hospital for prolonged convalescence.
Some authors have abandoned the transthoracic approach in favor of a transhiatal approach, which avoids a thoracotomy and places the anastomosis in the neck. 19 There are only a few randomized controlled studies with small numbers of patients that directly compare these two approaches. Goldminc et al 20 compared the clinical outcome of transhiatal and transthoracic esophagectomy in 67 patients with squamous cell cancer. There was no difference in pulmonary complications (19% vs. 20%), overall complication rates (56% vs. 46%), or postoperative death rates (6.2% vs. 8.5%). In a randomized controlled trial from this institution, transhiatal resection in 20 patients was compared with transthoracic resection in 19 patients. 21 There was no difference in postoperative cardiopulmonary complications or death between the two groups. We have favored the transthoracic approach because it allows a more controlled dissection and more complete lymphadenectomy, with a low hospital death rate.
We identified the use of postoperative epidural analgesia as an important contributor to the reduced death rate. This correlates with our clinical impression that improved pain control has led to a decrease in pulmonary complications. Watson and Allen, 22 in a study of 156 patients undergoing thoracoabdominal esophagectomy, reported a reduction in the incidence of pulmonary complications from 30% to 13% with the introduction of thoracic epidural analgesia, and a corresponding reduction in fatal pulmonary complications from 5% to zero. In a previous study from this institution of 578 patients who underwent transthoracic esophagectomy, it was shown that since the introduction of an anesthesiabased acute pain service, there has been a significant reduction in cardiopulmonary complications, death, and cost. 23 The aggressive use of bronchoscopy for the clearance of pulmonary secretions has also played an important role in reducing the number of deaths. It is performed as often as necessary in patients using topical anesthesia and without sedation, and has been well tolerated by our patients. Blood loss of more than 1,000 mL was predictive of death in this series, and the decrease in surgical blood loss with time reflects an evolving refinement in surgical technique. Decreased blood loss has been shown in other studies to correlate with a decreased hospital death rate after major cancer surgery such as hepatectomy. 24 In this study, the only preoperative factor that correlated with a decreased hospital death rate was a decrease in the number of patients with a significant history of smoking. Other authors have studied patient factors that contribute to hospital death and complications after esophagectomy. Ferguson et al 25 identified age and performance status as the optimal model for the preoperative prediction of risk of death in a study of 269 patients. Lund et al, 26 in a multivariate analysis of 657 patients, identified age, stage, and general patient status as the strongest predictors of death. In a similar analysis by Bartels et al 27 of 432 patients, compromised general status and poor cardiac, hepatic, and respiratory function were independent predictors of hospital death. Other studies have identified risk factors such as low PaO 2 , poor spirometry values, and low serum albumin levels. 28, 29 Although there may not be an ideal model for the assessment of surgical risk, preoperative performance status, particularly with regard to pulmonary risk, is likely to be the most important factor.
In summary, our data show that transthoracic esophagectomy for malignancy can be performed on an unselected patient population with a death rate of less than 5%, and approaching zero, in an experienced center. With increasing surgical experience, technical complications can be mini-mized. The challenge has been to reduce the incidence of major pulmonary complications, which are the leading cause of death. The implementation of management strategies aimed at reducing these complications, such as epidural analgesia and bronchoscopy, led to significant improvements in outcome in this series.
